These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18159163)

  • 1. [Association of interleukin-12 gene polymorphism with persistence of hepatitis B virus infection and hepatocellular carcinoma].
    Park JS; Cheong JY; Kang JK; Cho JH; Yu S; Shin HD; Park BL; Cho SW
    Korean J Gastroenterol; 2007 Nov; 50(5):313-8. PubMed ID: 18159163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide association study identifies new loci associated with risk of HBV infection and disease progression.
    Zeng Z; Liu H; Xu H; Lu H; Yu Y; Xu X; Yu M; Zhang T; Tian X; Xi H; Guan L; Zhang J; O'Brien SJ;
    BMC Med Genomics; 2021 Mar; 14(1):84. PubMed ID: 33736632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.
    Ren S; Lu J; Du X; Huang Y; Ma L; Huo H; Chen X; Wei L
    Cancer Immunol Immunother; 2012 Sep; 61(9):1433-9. PubMed ID: 22310928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DR genetic polymorphisms and hepatitis B virus mutations affect the risk of hepatocellular carcinoma in Han Chinese population.
    Zhao Y; Chen K; Yang H; Zhang F; Ding L; Liu Y; Zhang L; Zhang Y; Wang H; Deng Y
    Virol J; 2023 Nov; 20(1):283. PubMed ID: 38037048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. -509C>T polymorphism in the TGF-beta1 gene promoter, impact on the hepatocellular carcinoma risk in Chinese patients with chronic hepatitis B virus infection.
    Qi P; Chen YM; Wang H; Fang M; Ji Q; Zhao YP; Sun XJ; Liu Y; Gao CF
    Cancer Immunol Immunother; 2009 Sep; 58(9):1433-40. PubMed ID: 19169878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation analysis of IL-37 gene polymorphisms and susceptibility to chronic HBV infection among Han people in Central China.
    Cheng H; Sun F; Ouyang Y; Li C
    Int J Immunogenet; 2023 Dec; 50(6):299-305. PubMed ID: 37735774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphism in pri-microRNAs-371-372-373 with the occurrence of hepatocellular carcinoma in hepatitis B virus infected patients.
    Kwak MS; Lee DH; Cho Y; Cho EJ; Lee JH; Yu SJ; Yoon JH; Lee HS; Kim CY; Cheong JY; Cho SW; Shin HD; Kim YJ
    PLoS One; 2012; 7(7):e41983. PubMed ID: 22848681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of long noncoding RNA H19 rs2839698 C/T with hepatitis B virus infection and hepatocellular carcinoma risk.
    Motawi TK; Mady AE; Elhelbawy M; Talaat RM; Shahin NN
    J Biochem Mol Toxicol; 2024 Apr; 38(4):e23673. PubMed ID: 38481010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A genetic variant of the NTCP gene is associated with HBV infection status in a Chinese population.
    Yang J; Yang Y; Xia M; Wang L; Zhou W; Yang Y; Jiang Y; Wang H; Qian J; Jin L; Wang X
    BMC Cancer; 2016 Mar; 16():211. PubMed ID: 26968990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G susceptibility to hepatitis B infection and related hepatocellular carcinoma in the Japanese population.
    Okumura T; Joshita S; Yamazaki T; Iwadare T; Wakabayashi SI; Kobayashi H; Yamashita Y; Sugiura A; Kimura T; Ota M; Umemura T
    Hum Immunol; 2023 Aug; 84(8):401-407. PubMed ID: 37271588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in IL4RA, IL6, and IL12B genes and susceptibility to hepatitis B and C virus infections among Iraqi patients.
    Al-Saffar OB; Ad'hiah AH
    J Med Virol; 2020 Dec; 92(12):3448-3458. PubMed ID: 32652594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer dynein arm docking complex subunit 2 polymorphism rs7893462 modulates hepatocellular carcinoma susceptibility and can serve as an overall survival biomarker for hepatitis B virus-related hepatocellular carcinoma after hepatectomy: a cohort study with a long-term follow-up.
    Zeng Z; Liao X; Huang K; Han C; Qin W; Su H; Ye X; Yang C; Zhou X; Wei Y; Mo S; Liu J; Lan C; Huang X; Huang Z; Peng K; Gao Q; Peng T; Zhu G
    World J Surg Oncol; 2023 Oct; 21(1):322. PubMed ID: 37833735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentially functional genetic variants in ferroptosis-related CREB3 and GALNT14 genes predict survival of hepatitis B virus-related hepatocellular carcinoma.
    Zhan S; Qiu M; Wei X; Wei J; Qin L; Jiang B; Wen Q; Chen P; Lin Q; Wei X; Zhou Z; Jiang Y; Liang X; Li R; Liu Y; Yu H
    Cancer Med; 2024 Jan; 13(1):e6848. PubMed ID: 38151984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA Zygosity Increases Risk of Hepatitis B Virus-Associated Hepatocellular Carcinoma.
    Liu Z; Huang CJ; Huang YH; Pan MH; Lee MH; Yu KJ; Pfeiffer RM; Viard M; Yuki Y; Gao X; Carrington M; Chen CJ; Hildesheim A; Yang HI;
    J Infect Dis; 2021 Nov; 224(10):1796-1805. PubMed ID: 33852009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide functional integration identified MAZ-controlled RPS14 dysregulation in hepatocellular carcinoma.
    Han L; Huo Y; Huang L; Zheng Y; Yu X; Zhang N; Yang M
    Arch Toxicol; 2024 Mar; 98(3):985-997. PubMed ID: 38189915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UGT1A7 haplotype is associated with an increased risk of hepatocellular carcinoma in hepatitis B carriers.
    Kong SY; Ki CS; Yoo BC; Kim JW
    Cancer Sci; 2008 Feb; 99(2):340-4. PubMed ID: 18271934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of an Asian-prevalent HLA haplotype to the risk of HBV-related hepatocellular carcinoma.
    Kawamura A; Matsuda K; Murakami Y; Saruta M; Kohno T; Shiraishi K
    Sci Rep; 2023 Aug; 13(1):12944. PubMed ID: 37558689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High plasma interleukin-6 level, but not IL-6 gene variants, as a predictive marker for the development of hepatocellular carcinoma in a Moroccan population.
    Tanouti IA; Fellah H; Haddaji A; Zerrad C; Tahiri M; Badre W; Nfaoui K; Pineau P; Benjelloun S; Ezzikouri S
    Int J Immunogenet; 2024 Aug; 51(4):206-216. PubMed ID: 38563185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome.
    Truelove AL; Oleksyk TK; Shrestha S; Thio CL; Goedert JJ; Donfield SM; Kirk GD; Thomas DL; O'Brien SJ; Smith MW
    Int J Immunogenet; 2008 Jun; 35(3):255-64. PubMed ID: 18479293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex-differences in the association of interleukin-10 and interleukin-12 variants with the progression of hepatitis B virus infection in Caucasians.
    Fischer J; Koukoulioti E; Müller T; Heyne R; Eslam M; George J; Finkelmeier F; Waidmann O; Berg T; van Bömmel F
    Hepatol Res; 2023 Dec; 53(12):1156-1168. PubMed ID: 37565510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.